Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Zinc acetate

Generic Name: Zinc acetate

Brand Names: Banophen, Benadryl Itch Stopping, Caladryl Clear, Derma Gran, Galzin, Wal-dryl

Drug Type: Small Molecule

Chemical Formula: C_₄H_₆O_₄Zn

CAS Number: 557-34-6

Unique Ingredient Identifier: H2ZEY72PME

Overview

No overview information available.

Background

No background information available.

Indication

Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections .

Associated Conditions

Pruritus
Skin Irritation
Oozing and weeping
Pain and itching

Clinical Trials

Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders

Phase 2

Not yet recruiting

Posted: 2024/05/14

Sponsor:

Children's Universit...

ID:NCT06412653

Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers

Phase 2

Completed

Posted: 2016/08/16

Sponsor:Panineeya Mahavidyal...

ID:NCT02868151

A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc Deficiency

Phase 3

Completed

Posted: 2015/01/13

Sponsor:

Nobelpharma

ID:NCT02337569

Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency

Phase 3

Completed

Posted: 2014/12/22

Sponsor:

Nobelpharma

ID:NCT02321865

The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy

Phase 1

Completed

Posted: 2008/06/12

Sponsor:University of Michig...

ID:NCT00696410

FDA Approved Products

GALZIN

Manufacturer:Teva Pharmaceuticals USA, Inc.

Route:ORAL

Strength:25 mg in 1 1

Approved: 2023/08/16

NDC:57844-215

GALZIN

Manufacturer:Teva Pharmaceuticals USA, Inc.

Route:ORAL

Strength:50 mg in 1 1

Approved: 2023/08/16

NDC:57844-208

Itch Relief

Manufacturer:The Kroger Co

Route:TOPICAL

Strength:1 mg in 1 mL

Approved: 2025/03/31

NDC:59450-295

foster and thrive anti itch cream

Manufacturer:Strategic Sourcing Services LLC

Route:TOPICAL

Strength:0.1 g in 100 g

Approved: 2025/04/30

NDC:70677-1289

Singapore Approved Products

NUTRIFLEX® OMEGA SPECIAL EMULSION FOR INFUSION

Manufacturer:B. Braun Melsungen AG

Form:INJECTION, EMULSION

Strength:7.024mg/1000ml

Online:Yes

Approved: 2018/04/23

Approval:SIN15469P

NUTRIFLEX® OMEGA PLUS EMULSION FOR INFUSION

Manufacturer:B. Braun Melsungen AG

Form:INJECTION, EMULSION

Strength:5.264mg/1000ml

Online:Yes

Approved: 2018/04/23

Approval:SIN15468P

NUTRIFLEX® OMEGA SPECIAL B. BRAUN EMULSION FOR INFUSION

Manufacturer:B. Braun Melsungen AG

Form:INJECTION, EMULSION

Strength:7.024mg/1000ml

Online:Yes

Approved: 2023/03/07

Approval:SIN16734P

Related News

Eton Pharmaceuticals Poised for Growth with Expanding Rare Disease Portfolio and Pending FDA Approvals

2 months ago

Eton Pharmaceuticals is anticipating FDA approval for ET-400 in early June, with commercial launch planned immediately following approval and significant revenue impact expected in Q3 and Q4 2025.

Eton Pharmaceuticals Launches FDA-Approved Galzin for Wilson Disease Maintenance Treatment

3 months ago

Eton Pharmaceuticals has launched Galzin (zinc acetate) capsules, the only FDA-approved zinc therapy for Wilson disease maintenance treatment, offering improved access through their specialty pharmacy network.

FDA Extends Review Period for Eton Pharmaceuticals' Rare Disease Drug ET-400

4 months ago

The FDA has extended the PDUFA goal date for Eton Pharmaceuticals' ET-400 New Drug Application to May 28, 2025, requiring additional time to review supplemental information.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy